Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study
Authors
- Kan Yonemori (ORCID: https://orcid.org/0000-0002-7624-7611)
- Akiyo Yoshimura (ORCID: https://orcid.org/0000-0002-5274-9158)
- Toru Mukohara (ORCID: https://orcid.org/0000-0002-8573-418X)
- Yuko Mori (ORCID: https://orcid.org/0000-0003-1919-2463)
- Masaya Hattori (ORCID: https://orcid.org/0000-0002-0935-9269)
- Mana Aizawa
- Yoichi Naito (ORCID: https://orcid.org/0000-0002-8490-9064)
- Hiroji Iwata
- Junichiro Yoshimitsu
- Yoshiko Umeyama (ORCID: https://orcid.org/0000-0003-4967-0382)
Institutions
- Aichi Cancer Center (JP)
- National Cancer Center Hospital East (JP)
- Pfizer (Japan) (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1007/s10147-024-02648-3
- Citations
- 5
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 2.09